UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 18, 2005
WORLD HEART CORPORATION
(Exact name of registrant as specified in its charter)
Ontario 000-28882 N/A
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
incorporation)
7799 Pardee Lane
Oakland, California 94621
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (510) 563-5000
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
/_/ Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
/_/ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
/_/ Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
/_/ Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
On July 19, 2005, World Heart Corporation (the "Company") issued a press release
announcing that at its annual and special meeting of shareholders, held on July
18, 2005, the Company's shareholders approved the issuance of common shares by
the Company to MedQuest Products, Inc. ("MedQuest") in connection with the
acquisition by the Company of the business of MedQuest, and the private
placement of common shares of the Company to Maverick Venture Management, LLC.
In addition, the shareholders approved the reduction of the exercise price of
the warrants issued by the Company in September 2004 from $1.55 per share to
$1.00 per share for a period of 14 days following the approval of the
resolution.
A copy of the press release is furnished as Exhibit 99.1 to this report and
incorporated herein by reference.
Item 9.01. Financial Statements, Pro Forma Financial Information and
Exhibits.
(c) Exhibits.
The following exhibit is being filed herewith:
Exhibit No. Exhibit
- ----------- --------
99.1 Press Release, dated July 19, 2005, announcing the Approvals for
the MedQuest Acquisition and Maverick Private Placement at World
Heart Corporation's Annual and Special Shareholders Meeting.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: July 19, 2005
WORLD HEART CORPORATION
By: /s/ Richard Juelis
----------------------------------------------
Name: Richard Juelis
Title: Vice President, Finance and
Chief Financial Officer
EXHIBIT INDEX
Exhibit No. Exhibit
- ---------- ---------
99.1 Press Release, dated July 19, 2005, announcing the Approvals
for the MedQuest Acquisition and Maverick Private Placement at
World Heart Corporation's Annual and Special Shareholders
Meeting.